Presentation Information
[P1-053-B]Productivity and economic benefits of a freshly mixed vs a ready-to-used vaccine for Porcine CircoVirus type 2/ Mycoplasma hyopneumoniae disease control under Japanese field conditions.
*Sae Nikaido1, Shota Toya1 (1. Boehringer Ingelheim Animal Health Japan Co., Ltd. (Japan))
Keywords:
Porcine CircoVirus type 2,Mycoplasma hyopneumoniae,Vaccine